Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 30;13(1):90.
doi: 10.1038/s41408-023-00861-3.

Exercise-induced release of cardiac and skeletal muscle injury biomarkers in patients with chronic myeloid leukemia receiving TKI therapy

Lando Janssen  1   2 , Neeltje A E Allard  3 , Vincent L Aengevaeren  3 , Thijs M H Eijsvogels  3 , Silvie Timmers  4 , Nicole M A Blijlevens  5 , Maria T E Hopman  6
Affiliations

Exercise-induced release of cardiac and skeletal muscle injury biomarkers in patients with chronic myeloid leukemia receiving TKI therapy

Lando Janssen et al. Blood Cancer J. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors have contributed significantly and are in agreement with the content of the manuscript. No author has conflict of interest related to this work.

Figures

Fig. 1
Fig. 1. High-sensitivity cardiac Troponin I (hs-cTnI) concentrations across groups at baseline, directly post-exercise and 2 h post-exercise.
Symbols represent individual values. Boxes represent interquartile (25th to 75th percentile) ranges, whiskers represent minimal and maximal values, and the horizontal line indicates median. Directly post-exercise, data of one patient in the nilotinib group was missing due to technical difficulties. Abbreviations: hs-cTnI high-sensitivity cardiac Troponin I; URL upper reference limit.
Fig. 2
Fig. 2. Creatine kinase (CK) concentrations across groups at baseline, directly post-exercise and 2 h post-exercise.
Symbols represent individual values. Boxes represent interquartile (25th to 75th percentile) ranges, whiskers represent minimal and maximal values, and the horizontal line indicates median. Data of one patient in the nilotinib group and one patient in the imatinib group was missing at baseline, and data of one imatinib-treated patient was missing directly after exercise due to technical difficulties. hs-cTnI high-sensitivity cardiac Troponin I, URL upper reference limit.
See this image and copyright information in PMC

References

    1. Lipton JH, Brümmendorf TH, Gambacorti-Passerini C, Garcia-Gutiérrez V, Deininger MW, Cortes JE. Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia-What to look for when treatment-free remission is not an option. Blood Rev. 2022;56:100968. doi: 10.1016/j.blre.2022.100968. - DOI - PubMed
    1. Franklin BA, Eijsvogels TMH, Pandey A, Quindry J, Toth PP. Physical activity, cardiorespiratory fitness, and cardiovascular health: a clinical practice statement of the ASPC part I: bioenergetics, contemporary physical activity recommendations, benefits, risks, extreme exercise regimens, potential maladaptations. Am J Prev Cardiol. 2022;12:100424. doi: 10.1016/j.ajpc.2022.100424. - DOI - PMC - PubMed
    1. Lando J, Nicole MAB, Meggie MCMD, Esmée AB, Malou AHN, Jeroen JWMJ, et al. Fatigue in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy: predictors and the relationship with physical activity. Haematologica. 2020;106:1876–82.. doi: 10.3324/haematol.2020.247767. - DOI - PMC - PubMed
    1. Janssen L, Hopman MTE, Swaans GJA, Allard NAE, Boss M, Lobeek D, et al. Impact of tyrosine kinase inhibitors on glucose control and insulin regulation in chronic myeloid leukemia patients. Am J Physiol Endocrinol Metab. 2023;324:E209–16. - PubMed
    1. Everett BM, Brooks MM, Vlachos HEA, Chaitman BR, Frye RL, Bhatt DL. Troponin and cardiac events in stable ischemic heart disease and diabetes. N Engl J Med. 2015;373:610–20. doi: 10.1056/NEJMoa1415921. - DOI - PMC - PubMed